The review said a certain class of drugs had little clinical benefit, but many Alzheimer’s experts criticized the analysis, saying it unfairly lumped failed drugs with two recently approved treatments.
from NYT > Health https://ift.tt/HCwxr9z
Subscribe to:
Post Comments (Atom)
-
Low density lipoprotein or simply known as cholesterol is dangerous to the heart and can lead to heart attack and stroke, but the good thing... -
A long stay in intensive care can bring physical, cognitive and mental health challenges that can take months or longer to resolve. from N...
-
Captive animals sometimes need a transfusion, but the typical approach to blood banking isn’t practical for zoos and aquariums. One veterina...
No comments:
Post a Comment